PRESS RELEASES
DNA Script Joins Wellcome Leap R3 Program to Advance RNA Products and Therapies
February 2, 2022Multi-year, multi-million dollar collaboration will develop new tools to rapidly accelerate the development of RNA-based products, catalyzing a new era …
▶
▶
PRESS RELEASES
DNA Script to Present at 40th Annual J.P. Morgan Healthcare Conference
January 5, 2022Company to Webcast Presentation Monday, January 10, 2022, at 2 p.m. EST DNA Script, a leader in Enzymatic DNA Synthesis …
▶
▶
PRESS RELEASES
DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche
January 4, 2022Accounts and funds advised by T. Rowe Price Associates, Inc. and Baillie Gifford join syndicate of investors Funding to accelerate …
▶
▶
PRESS RELEASES
DNA Script Obtains CE Mark for SYNTAX DNA Printing Platform
November 30, 2021DNA Script, a leader in Enzymatic DNA Synthesis (EDS), announced the CE marking of its SYNTAX System, the first EDS-powered …
▶
▶
PRESS RELEASES
DNA Script Welcomes Blanche Savary de Beauregard as General Counsel
November 16, 2021DNA Script, a leader in Enzymatic DNA Synthesis (EDS), announced that Blanche Savary de Beauregard has joined the company as …
▶
▶
PRESS RELEASES
DNA Script to Develop Next Generation of Enzymatic DNA Synthesis Printers with $2.2 Million Grant Award from the National Human Genome Research Institute of the NIH
November 9, 2021Designed to bypass the oligo bottleneck in genomic research and development, the new platform will build on the success of …
▶
▶
PRESS RELEASES
DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform
October 26, 2021New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Total Amount Raised to Date to $280M DNA Script, …
▶
▶
PRESS RELEASES
DNA Script Appoints Don Kania as Chairman of the Board of Directors, Catherine Moukheibir as Audit Chair and Bonnie Anderson as Independent Director
October 21, 2021DNA Script, a leader in Enzymatic DNA Synthesis (EDS), today announced the appointment of Don Kania, Ph.D. as Chairman of …
▶
▶
PRESS RELEASES
GP-write Partners with DNA Script to Accelerate DNA-Writing Technology and Accessibility
October 18, 2021Genome Project-write (GP-write) welcomes DNA Script as one of the newest members of its Industrial Advisory Board (IAB). Together with …
▶
▶
AWARDS, PRESS RELEASES
DNA Script Wins the Biotech / Medtech Trophy at the Future Unicorns Ceremony
September 30, 2021DNA Script, developer of the SYNTAX System, the first DNA printer using Enzymatic DNA Synthesis (EDS) technology, won the Biotech …
▶
▶
PRESS RELEASES
DNA Script Announces the Commercial Launch of the SYNTAX System, the First Benchtop DNA Printer Powered by Enzymatic Synthesis, to Accelerate Molecular Biology and Genomics Workflows
June 15, 2021The SYNTAX System Prints DNA on Demand, Bringing Workflow Control Back to the Lab SOUTH SAN FRANCISCO, Calif., and PARIS, …
▶
▶
PRESS RELEASES
DNA Script Names Expanded Leadership Team to Pilot Commercial Launch of SYNTAX System and Accelerate Company Growth
June 8, 2021Illumina Veteran Kim Ferguson Joins as Vice President of Sales and Randy Dyer, an Experienced Leader in Life Science Marketing, …
▶
▶
PRESS RELEASES
DNA Script Advances Evaluation Program for the SYNTAX System, the First Benchtop DNA Printer Powered By Enzymatic Synthesis
May 20, 2021The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster DNA Script, a leading …
▶
▶
PRESS RELEASES
DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA
April 27, 2021Company will receive up to $5 Million in grant funds from DARPA as part of the agency’s Nucleic Acids On-Demand …
▶
▶
PRESS RELEASES
DNA Script Names Philippe Lyko as Chief Financial Officer
March 23, 2021Former Illumina and Helix finance executive brings deep experience with emerging and established life science companies DNA Script, a leader …
▶
▶
